Latest News & Features
Americas
Pharmaceutical research company Phigenix lost an appeal at the US Court of Appeals for the Federal Circuit yesterday, after the court found that the company lacked standing in a patent case against ImmunoGen. 10 January 2017
Biotechnology
Several changes have been made to Italy’s regulatory landscape for biosimilars, as Luca Tosoni of Covington & Burling reports. 10 January 2017
Americas
Sanofi and Regeneron Pharmaceuticals have revealed plans to appeal against an injunction granted to Amgen, which prevents the companies from selling cholesterol-lowering medicine Praluent. 9 January 2017
Americas
Sanofi and Regeneron Pharmaceuticals must stop selling cholesterol-lowering medicine Praluent after Amgen obtained an injunction against the companies. 6 January 2017
Americas
Healthcare company Fresenius Kabi has targeted Sagent Pharmaceuticals in a patent infringement lawsuit centring on generic versions of Naropin. 6 January 2017
Biotechnology
The English High Court has dismissed an application for summary judgment from pharmaceutical company AbbVie. 6 January 2017
Americas
US-based law firm Offit Kurman has boosted its expertise in Virginia with the appointment of Christopher Raimund as a principal in the intellectual property practice. 5 January 2017
Americas
Par Pharmaceutical has sought a declaratory judgment that it did not infringe patents belonging to Sumitomo and its subsidiary Sunovion that protect bipolar disorder drug Latuda. 5 January 2017
Americas
IP law has yet to catch up with the technological capabilities of 3D printing, but by taking pre-emptive action, companies can maximise their IP protection under the current legal framework. Arlene Chow and Nitya Anand of Hogan Lovells report. 5 January 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid. 4 January 2017